Kidney Cancer | Topics

Sunitinib Treatment Improved Survival for Malignant Pheochromocytoma and Paraganglioma
September 20, 2021

Treatment with sunitinib resulted in improved efficacy results in the FIRSTMAPPP trial for patients with malignant pheochromocytoma and paraganglioma.

Perioperative Cabozantinib Demonstrates Promise in Metastatic Renal Cell Carcinoma
September 18, 2021

Patients with intermediate- and poor-risk metastatic renal cell carcinoma experienced promising responses after being treated with perioperative cabozantinib.

Cabozantinib Demonstrates Real-World Survival Benefit in Patients With Pre-Treated Advanced Renal Cell Carcinoma
September 18, 2021

Those with advanced renal cell carcinoma whose disease was previously treated experienced long-lasting and robust overall survival following treatment with cabozantinib.